- Report
- May 2022
- 240 Pages
Global
From €2896EUR$3,300USD£2,506GBP
- Report
- December 2021
- 120 Pages
Global
From €2896EUR$3,300USD£2,506GBP
- Report
- July 2024
- 500 Pages
Turkey
From €2896EUR$3,300USD£2,506GBP
- Report
- January 2023
- 189 Pages
Global
From €3686EUR$4,200USD£3,189GBP
- Report
- September 2024
- 120 Pages
China
From €5222EUR$5,950USD£4,518GBP
- Report
- May 2024
- 150 Pages
Global
From €5222EUR$5,950USD£4,518GBP
- Report
- September 2022
- 247 Pages
Global
From €2304EUR$2,625USD£1,993GBP
€4607EUR$5,250USD£3,987GBP
- Report
- May 2024
- 137 Pages
Global
From €5704EUR$6,499USD£4,935GBP
- Report
- January 2024
- 200 Pages
Global
From €3642EUR$4,150USD£3,151GBP
- Report
- May 2024
- 298 Pages
Global
From €6977EUR$7,950USD£6,037GBP
- Report
- February 2024
- 245 Pages
Global
From €6977EUR$7,950USD£6,037GBP
- Report
- April 2023
- 350 Pages
Global
From €2852EUR$3,250USD£2,468GBP
- Report
- October 2022
- 100 Pages
Global
From €2194EUR$2,500USD£1,898GBP
- Report
- September 2022
- 239 Pages
Global
From €6582EUR$7,500USD£5,695GBP
- Report
- July 2024
- 150 Pages
Global
From €3291EUR$3,750USD£2,848GBP
- Report
- July 2024
- 150 Pages
Global
From €3291EUR$3,750USD£2,848GBP
- Drug Pipelines
- July 2024
- 100 Pages
Global
From €3291EUR$3,750USD£2,848GBP
- Report
- April 2023
- 118 Pages
Global
From €4169EUR$4,750USD£3,607GBP
- Report
- April 2023
- 119 Pages
Global
From €4169EUR$4,750USD£3,607GBP
- Report
- February 2024
- 210 Pages
Global
From €2984EUR$3,400USD£2,582GBP
€3730EUR$4,250USD£3,227GBP

BeiGene is a market within the context of Oncology Drugs, which are drugs used to treat cancer. These drugs are used to target and destroy cancer cells, while minimizing damage to healthy cells. BeiGene is a biopharmaceutical company that develops and commercializes innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company focuses on developing therapies that target cancer cells with precision and accuracy, while also providing a safe and effective treatment for patients. BeiGene's portfolio includes a range of drugs, including small molecules, antibodies, and other biologics. The company also has a pipeline of novel therapies in development.
BeiGene is one of many companies in the Oncology Drugs market. Other companies include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more